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ABSTRACT
In this thesis, we examine epidemiological models of two different retroviruses, which infect the
human body. The two viruses under study are HIV or the human immunodefiency virus and
HTLV-I, which is the human T lymphotropic virus type I. A retrovirus is a virus, which injects
its RNA into the host, rather than it’s DNA. We will study each of the different mathematical
models for each of the viruses separately. Then we use MATLAB-SIMULINK to analyze the
models by studying the reproductive numbers in each case and the disease progression by
examining the graphs. In Chapter 1, we mention basic ideas associated with HIV and HTLV-I. In
Chapter 2 some of the basic mathematical model of epidemiology is presented. Chapter 3 is
devoted to a model describing the intra-host dynamics of HIV. Here, we take into account how
HIV infects and replicates in the CD4+ T cells. The model studied in this thesis examines the
difference between cells, which are susceptible to the virus, and cells, which are not susceptible.
Through the graphs associated with this model, we are able to see how this difference affects
disease progression. In Chapter 4, we examine the effect of HTLV-I virus on human body. The
HTLV-I virus causes a chronic infection in humans and may eventually lead to other diseases.
In particular, the development of Adult T-cell Leukemia or ATL is studied in this thesis. The Tcell dynamics and progression to ATL is described using a mathematical model with coupled
differential equations. Using mathematical analysis and SIMULINK, we obtain results on
stability, asymptotic stability and the manner of progression of the disease. In Chapter 5 and
appendices, we mention our inference and the MATLAB-SIMULINK codes used in this thesis,
so that a reader can verify the details of the work carried out in this thesis.
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CHAPTER ONE - INTRODUCTION
1.1 Introduction
Disease has played an important part throughout the history of mankind. Diseases have
influenced the growth or decline of a population and have impact on the economy. It causes
more deaths than any other source, including war and natural disasters. The manner in which
diseases infect and invade a population has perplexed doctors and scientist for many years. A
branch of science called epidemiology was developed in order to help analyze and understand
the spread of disease.
Aristotle and Hippocrates of Cos started studying the transmission of diseases during
300BC-400BC. Later, germ theory was first studied by Jacob Henle in 1840 and was later
developed by Robert Koch, Joseph Lister, and Louis Pasteur. Modern mathematics was first
used in the study of diseases in 1873 by P.D En'ko. Sir R. A. Ross, W. H. Hamer, A.G
Mckendrick, and W. O Kermack laid the foundation of mathematics in epidemiology between
1900 and 1935. (See [15]) The study of epidemiology has grown tremendously since and most
known communicable diseases have been modeled and analyzed.
Epidemiology not only helps us to understand disease transmission, but also to know how
to control the spread of a particular disease. It is not a static science and is constantly changing.
Infectious diseases are constantly evolving and changing, making them harder to control. New
strains, which are immune to antibiotics, are found everyday. HIV and HTLV-I are two new
viruses which were first discovered in the 1980’s. These viruses have no known cure but doctors
are working with epidemiologist, mathematicians, and scientist to find a cure and limit its
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transmission. We will use mathematical models to help us understand the spread of these viruses
in the human body and the progression of these viruses to disease.

1.2 Introduction to HIV
In 1981 the Center for Disease Control reported on an unusual collection of homosexual
males that had Pneumocyctis carinii pneumonia and Kaposi’s sarcoma. These men were
previously healthy individuals. This was a new retroviral disease later to be named AIDS or
Acquired Immunodeficiency Syndrome, a disease for which there is still no cure and is the
fourth leading cause of death worldwide. The etiologic agent of this new epidemic is the human
immunodeficiency virus or HIV, which will be studied in detail in this thesis. HIV is the
retrovirus which causes AIDS. This virus slowly destroys the immune system over many years.
Once the immune system is depleted, AIDS occurs.
AIDS was first discovered in the United States but now affects the entire world and is
considered the new “plague”. It has killed more than 25 million people worldwide and is
considered the most destructive epidemic in recorded history. AIDS is now found in more than
163 countries with the most being in Africa and the Caribbean being the second. Sub-Saharan
Africa is considered to be the global epicenter of the HIV epidemic. (See [5]) Ninety percent of
the individuals infected with HIV are in developing countries and forty percent of those infected
are females. Individuals in the 15-24 age group are the fastest growing segment who are being
infected with HIV.
HIV can be transmitted in different ways. The virus is present in bodily fluids,
specifically blood, therefore, any activity that results in the transfer of bodily fluid can
potentially result in the transfer of HIV. Intimate sexual contact is one of the modes in which
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fluid transfer occurs. Intravenous drug use is another mode in which HIV is transmitted between
individuals because many drug users share needles. Two other modes which are not as common
due to medical advances and new antiretroviral drugs are mother to child transmission and
transmission through blood transfusion. Mother to child transmission can occur during the
birthing process or through breast feeding. Although the rate of mother to child transmission has
dropped in many developing countries, it is still very prevalent in the sub-Saharan regions of
Africa. Transmission due to blood transfusions are rarely seen today due to examination of the
blood from donors for presence of HIV prior to saving them in the blood bank for patient use.
The U.S. blood supply is very safe due to the extensive questioning of blood donors and the
extensive testing of donated blood.
HIV is characterized by immunosuppression, neurologic involvement and secondary
tumors. HIV attacks the CD4+ T-cells, which are responsible for the immune system. The
nature of this attack and how it occurs is modeled mathematically in Chapter Three in order to
help us understand and predict the course of the disease. Many graphs developed from the
mathematical model help demonstrate the progression to AIDS. The graphs were produced
using Simulink and match those produced by Stilianakis and Schenzle in Fortran.

1.3 Introduction to HTLV-I
Human T-lymphotropic virus (HTLV-I) was the first retrovirus to be discovered. This
virus was discovered in Japan in 1980. HTLV-I is a virus which lays latent for many years
before causing other diseases to proliferate. This virus is the predominant cause of two diseases.
The first one is Adult T Cell leukemia/lymphoma or ATL, which is a T cell non-Hodgkin’s
lymphoma with a leukemic phase of circulating CD4+T cells. The progression from HTLV-I to
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ATL is mathematically modeled and studied in Chapter 4. The discovery of HTLV-I provided
scientists with a clear proof of a relationship between viruses and cancer. The second disease
that is cause by HTLV-I is myelopathy (HAM) which is also known as tropical spastic para
paresis (TSP). Usually this virus does not produce disease until approximately twenty years after
initial infection. HTLV-I can also cause autoimmune or chronic inflammatory disorders such as
arthropathy, Sjogren’s syndrome and facial nerve palsy. Identification of the HTLV-I virus
facilitated the discovery and isolation of HIV.
HTLV-I infects ten to twenty million people world wide but only produces disease in
approximately five percent of infected individuals. Women are twice as likely to contract
HTLV-I as men. The HTLV-I infection is thought to occur in geographical clusters which are
located in southern Japan, the Caribbean, parts of Africa, the Middle East, South America,
Pacific Melanesian islands, and Papua New Guinea. The virus is also found in the southeastern
United States in certain immigrant groups.
HTLV-I is transmitted in the same way as HIV, through bodily fluid transfer. Unlike
HIV, the main transmission is through breast feeding. The HTLV-I antigen is found in the
infected mother’s milk and is transmitted most likely through lymphocytes in the milk. The
prevalence of this vertical transmission through breast feeding has caused a clustering of cases in
familial or geographically discrete groups. (See [14]) Other modes of are sexual transmission,
infection from blood transfusion, and sharing needles among drug users.
Many people can be infected with HTLV-I and will never develop a disease from this
virus. Chapter Four will feature a mathematical model of the HTLV-I infection of CD4+ T-cells
and the eventual progression to ATL. The stability analysis will illustrate two different steady
states. One steady state when the virus will not progress to ATL, and another steady state when
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the virus will progress to ATL. A proposition for asymptotical stability is studied and a graph
was produced using Simulink. Even after rigorous analysis, this graph does not match the graph
presented by the authors and further work may be needed in order to explore the difference.
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CHAPTER TWO – BACKGROUND STUDY
2.1 Introduction to mathematical models
A mathematical model is a mathematical description of a real world system or event. (See
[12]) Epidemiologists will use mathematical models in order to understand and predict the
course of an infection or disease. A well-formulated model can help an epidemiologist
determine where resources need to be allocated and how those resources can help control or
eradication of the disease. In order to formulate a model for an infectious disease, an individual
must first collect an abundance of empirical data through clinical testing. Once this data is
collected and analyzed, the modelers develop a model using the following steps. Firstly, they
note all the relevant assumptions, and then determine the relationship between the variables and
parameters used in the model and finally, analyze any specific patterns that are found. Deciding
which parameters and variables will be used in the model and how much importance should be
given depend on the characteristics of the disease under study and the intention of the model.
(See [2]) Once the model is formulated and analyzed, it will help the scientists to draw
inferences form a set of hypotheses in order to determine the course of the disease in an
individual or in a population.
Epidemiological models are usually formed using the general MSEIR model. This model
places individuals from a constant population into certain groups within the model and describes
the transition rate between each group. Each letter represents a different class or group. M
represents the temporary immunity that a mother can pass on to her child through the placenta.
The S describes the susceptibles, which are the members of the population who are at risk for
contracting the disease. E stands for exposed and describes the individuals from the population
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who are infected by the disease but are not infectious due to a latent period of a disease. The I
group is the Infectious group or the individuals from the population who have the ability to pass
the disease to other members of the population. R represents the group of individuals who have
recovered from the disease, whether temporary or permanent, and also possess some type of
immunity.

2.2 Basic SIR Model
The first model to consider is the basic SIR model. It is a simple epidemic model
developed by Kermack and McKendrick in 1927 to predict the behavior of many historical
epidemics such as cholera, influenza, and the Great Plague. This model is used by many
epidemiologists because it can help predict the behavior and progress of different diseases. This
model is also a building block for many of the other more complicated models. The SIR model
considers a population that remains constant. The population is divided into three classes: first,
the individuals who are susceptible, S, to the disease, second, the individuals being exposed and
infected by the disease, I, and last the individuals who will recover, R, from the infection and
gain immunity to the disease. This model does not consider any latent period of the disease.
Once an individual is infected, he is automatically moved into the infectious classification. The
progress of the individuals from class to class can be demonstrated by

S

I

R

Some models only consider the S and I classes. Other models consider a fourth class, E, which
takes in account a latent period of the disease in which the virus is present in the host but has not
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infected the host. When modeling a disease like AIDS, it is better to use a model which includes
this class.
This model makes many assumptions. We must first assume the collection of
individuals in each class is a differentiable function of time. This is reasonable as long as there
are enough people in each class. Next, the model is deterministic. This means that the behavior
of the model is determined by the past behavior of diseases. A stochastic model would be more
effective if the model described classes with small populations. Third, this model does not
include a latent phase of the disease, which means that once a susceptible becomes infected, the
individual is automatically placed into the infected class. Fourth, the model assumes that an
infected individual makes contact significant enough to transmit the disease at the contact rate,

β . If β N

S
I = β SI , new cases will occur when N is the total number in the population, S is
N

the number of susceptibles and I is the number of infecteds. The fifth assumption is that the
model has a mass action principle, which means every individual within the population has an
equal chance to have contact with every other individual in the population. This information
implies that β , the contact rate, is the ratio of rate of contact to the population size. Another
assumption is that the recovery rate is proportional to the number of infecteds, and is represented
by aI, where a is the removal rate. The last assumption is that there is no entry or exit from the
population except through death. This occurs when the progression to disease is so quick that
birth and death rates can be ignored. This assumption can be changed in certain models.
Based on these assumptions, the classic Kermack and McKendrick model is:

dS
= − β SI
dt

(2.1)

dI
= β SI − aI
dt

(2.2)
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dR
= aI
dt

(2.3)

Note that only non-negative solutions for S, I and R are of interest. Also, remember the total
population is constant and is embedded in the model. If we add equations (2.1)-(2.3), we will
get:

dS dI dR
+ +
=0
dt dt dt

(2.4)

Solving this differential equation will yield:

S (t ) + I (t ) + R(t ) = N

(2.5)

where N is the population size. We also have the following initial conditions:
S (0) = S0 , I (0) = I 0 , R(0) = R0

(2.6)

where S0 > 0 and I 0 > 0 .
The population is constant, therefore, R can be determined if S and I are known. For this
reason, equation (2.3) can be dropped and the system can be reduced to only two equations. This
system is not possible to solve analytically but the equations can be analyzed using a qualitative
approach. Note that S ′ < 0 and I ′ > 0 if S0 >

a

β

. Since S is decreasing, I will initially increase

but then will decrease to zero. The possibility of I increasing is what indicates an epidemic
because I represents the infected individuals. If S0 <

epidemic. If S0 >

a

β

a

β

, then I will go to zero and there is no

, the number of infected individuals will first increase to S =

a

β

, and then

decrease to zero. From this, we see a threshold parameter. The behavior of the disease will
depend on the threshold quantity,

S0 β
. This number defines the reproduction number. The
a

9

reproduction number, R0 , of the system is defined as the number of secondary infections
produced by one primary infection in the population of susceptibles. Therefore:
R0 =

S0 β
a

(2.7)

This number measures how fast the infection will spread. If R0 < 1 , the infection will not
continue and the disease will disappear. If R0 = 1 , the infection will remain stable in
transmission. If R0 > 1 , an epidemic will occur. (See [3]) To find the trajectories in the phase
plane, we first divide the two equations of the model and get:
dI ( β S − a ) I
a
=
= −1 +
dS
− β SI
βS

(2.8)

Separation of variables and integration yields:
I = −S +

a

β

log S + c

(2.9)

where c is an arbitrary constant of integration. Equation (2.9) can be defined as the following
quantity:
J (S , I ) = S + I −

a

β

log S

(2.10)

where J(S,I)=c. Different constants will give different trajectories and this constant can be
obtained by knowing the initial values of S , I , S0 and I 0 . We now have:
J ( S0 , I 0 ) = S0 + I 0 −

a

β
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log S0 = c

(2.11)

If we assume a population of size K and introduce a small number of infecteds into the
population so S0 ≈ K and I 0 ≈ 0 , we can determine R0 =

βK
a

from equation (2.7). Taking the

fact that lim I (t ) = 0 and lim S (t ) = S∞ , we can find J ( S0 , I 0 ) = J ( S∞ , 0) . This will yield:
t →∞

t →∞

K−

a

β

log S0 = S∞ −

a

β

log S∞

(2.12)

This helps to determine the reproduction number because it will give an expression for

β
a

in

parameters that can be determined:
K − S∞ =

a

β

log

S0
S∞

S0
S∞
β
=
a K − S∞

(2.13)

log

(2.14)

Note S0 > S∞ because the initial number of susceptible will be greater than the number of
susceptible who will become infected. This will occur because there are some who will not
come into contact with the disease.

2.3 Basic SIS Model

The SIS model is another type of model to study infectious diseases. In this model, the
infected will return to the susceptible class after recovery. This model is more effective to use
when studying sexually transmitted diseases. The simplest model, which was also given by
Kermack and McKendrick is:
dS
= − β SI + aI
dt

11

(2.15)

dI
= β SI − aI
dt

(2.16)

This model is different than the SIR model in that the recovered members will return to the
susceptible class at a rate of aI instead of moving to a recovered class. Just as in the SIR model
the total population is constant, since ( S + I )′ = 0 . Again, let the constant population be

represented by K. If K = S + I , we can replace S by K-I and reduce the model to a single
differential equation. This equation is:
dI
= β I ( K − I ) − aI
dt
= ( β K − a) I − β I 2

(2.17)

I

= ( β K − a ) I (1 −

K−

a

)

β

This is a logistic equation with a growth rate of β K − a and a carrying capacity of K −

analysis of this will show that if β K − a < 0 or
lim I (t ) = 0 and lim S (t ) = K . If
t →∞

t →∞

and lim S (t ) =
t →∞

a

β

βK
a

βK
a

a

β

. An

< 1 , then for any I 0 > 0 , we see that

> 1 , then for any I 0 > 0 , we will see that lim I (t ) = K −
t →∞

a

β

. As seen here, there is a single limiting value for I and this limiting value is

determined by the quantity,

βK
a

, regardless of the initial rate of infection. The infection will

disappear or the number of infected will approach zero when

I=0 and S=K is considered the disease free equilibrium. If
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βK
a

βK
a

< 1 . Hence the equilibrium

> 1 , the infection will continue.

The equilibrium, I = K −

β
a

, which corresponds to S =

a

β

, is defined as the endemic

equilibrium.
The dimensionless quantity,

R0 =

βK
a

βK
a

, is the reproduction number for our system, noted as

. In Section (2.2), we discussed that the value of R0 was the threshold parameter. We

also defined R0 , as the number of secondary infections produced by one primary infection in the
population of susceptible. The reproduction number helps determine the path which the disease
will take. If R0 =
unit of time and

βK
a

, where β K is the number of contacts made by an average infected per

1
is the mean infected period, we can clearly see if R0 < 1 , the infection will
a

disappear and if R0 > 1 , the infection will persist.
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CHAPTER THREE – INTRA-HOST DYNAMICS OF HIV
3.1 Introduction to intra-host dynamics of HIV

To understand how HIV destroys the immune system, we first must understand how the
immune system works. When a foreign substance, or antigen, enters the body, the body will
initiate an immune response. This immune response starts with macrophages and monocytes.
These cells are the body’s first defense against the antigen. They will seek out the antigen,
surround it and overtake it. This process is known as phagocytosis. The macrophages will then
analyze the content of the antigen and pass this information along to the CD4+ T lymphocytes,
also called CD4+ T cells. The CD4+ T cells will call for the production of more CD4+T- cells
or will call for the production of types of T-cells such as the CD+8-T cells. Another weapon
used by the body’s defense system is the B lymphocytes or B cells. These cell produce
antibodies specifically engineered to destroy the pathogen detected by the macrophages. (See
[7])
HIV is considered a lentivirus, meaning slow virus, which is a subclass of the retrovirus.
In general, a virus will insert their own DNA into the host cell. When the host cell replicates
their DNA, the virus’ DNA is also replicated. A retrovirus, like HIV, will insert RNA rather
than DNA into the host. Retroviruses have a unique enzyme , reverse transcriptase. (See [5]).
This enzyme will prepare a DNA copy of the RNA genome into the host. This DNA copy is
eventually inserted into the genome of the host cell where the virus will persist for years and is
impossible to eradicate. (See [19]) The HIV DNA will get copied every time the host cell
divides.
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On the cellular level, the HIV particles target the CD4+ T lymphocyte. It attracts the
CD4+T-lymphocyte through a glycoprotein called gp120. The protein enzyme, gp120, is located
on the surface of the HIV particle and it is attracted to the CD4 protein on the surface of the T-c
ells, macrophages, and monocytes. The CD4+ T cell attaches itself to the virus and is infected.
The HIV infection can typically be divided into three phases. The first phase is the
primary infection. During this initial phase, the virus is present in the host and replicates in the
manner describe previously. Three to six weeks after infection, 50-75% of patients develop an
acute viral syndrome. (See [19]) There is also a significant reduction of CD4+ T cells. The
second phase of HIV infection is the longest phase. It is the phase in which there is a long
asymptomatic period and latency occurs. There are two major features of this phase. The first
feature is the permanent viral replication in the lymphatic tissue and lymphoid organs. The
second feature is the gradual decline of the CD4+ T cells. The final phase of the HIV infection
shows a sharp decline of CD4+ T cells and the emergence of clinical immunodeficiency and
progression to AIDS. The period of time from initial infection to the formation of AIDS can
vary from person to person. The median estimate is eight to eleven years without treatment and
even longer with treatment.

3.2 HIV Simple Model

Stilianakis and Schenzle developed this basic model to describe the long term dynamics
of HIV progression through the body and the eventual development of AIDS. The basic
biomedical assumption of this model is the genetic variation of HIV. It is assumed that the
infection rate is the major source for the increase and selection of the HIV mutants.
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Table 1: Variables used in the simple model
Variable
Total number of susceptible CD4+ T cells
X
Total number of productively infected CD4+
Y
T cells
Total number of HIV particles
V
Factor that describes the increase of the
K
CD4+ T cell infection rate

The model consists of the following non-linear differential equations:

dX
= Λ − μ X − κ 0 KVX
dt

(3.1)

dY
= κ 0 KVX − δ Y
dt

(3.2)

dV
= βY − γV
dt

(3.3)

dK
= ωKV ( K max − K )
dt

(3.4)

The biological representation of each term in each equation will now be discussed in
order to provide a better understanding of the system. In the first equation, equation (3.1), Λ
represents the constant rate at which new CD4+ Tcells are produced. These newly produced
CD4+ T cells are considered to be susceptible. The term μX is the rate at which susceptible cells
die. The last term, κ 0 KVX , is considered a mass action term which describes the rate at which
susceptible cells are infected by the HIV particles. This mass action term is also seen in the first
term of equation (3.2). The second term in equation (3.2) is δ Y . This term describes the death
rate of the infected CD4+ T cells.
The first term in equation (3.3) is βY. This term represents the rate in which infectious
viral particles infect the CD4+ T cells. γV represents the rate at which virus particles are cleared.
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In the last equation, equation (3.4), one term is seen. This equation represents how fast the virus
can reproduce within the host and the maximum amount of virus particles that can be see within
the host at any particular time within the evolutionary process.
The rate at which the virus reproduces is called the virus reproduction number. In this
model it is a dynamic quantity and it changes over time. The virus reproduction number is:

R0 (t ) =

βκ 0 K (t ) X 0
δγ

(3.5)

This reproduction number will increase monotonically toward:

R *0 =

βκ 0 K max X 0
δγ

(3.6)

3.3 HIV Extended model

The following model is an extension of the original basic model. The extended model
takes into account the total number of susceptible CD4+ T cells and how fast new CD4+ T cells
become susceptible to the HIV infection.
Table 2: Variables used in the extended model
Variable
Total number of non-susceptible CD4+ T
X
cells
Total number of susceptible CD4+ T cells
S

Initial Values
X (0) = X 0 = 0.7 × 2.5 × 1011

S (0) = S0 = 0.3 × 2.5 ×1011
Y (0) = Y0 = 0

V

Total number of productively infected
CD4+ T cells
Total number of HIV particles

V (0) = V0 = 1

Z

Anti-HIV activity of the immune system

Z (0) = Z 0 = 10−6

P

Fraction of new CD4+ T cells entering the
pool of susceptible CD4+ T cells
Factor that describes the increase of the
CD4+ T cell infection rate
Total number of uninfected CD4+ T cells

P (0) = P0 = 0.3

Y

K
N
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K (0) = K 0 = 1.0
N (0) = N 0 = X 0 + S0 = 2.5 ×1011

The model consists of the following non-linear differential equations:
dX
= α (1 − P) − μ X
dt

(3.5)

dS
S
= α P − μ S − κ 0 KV
dt
(P + d )

(3.6)

dY
S
= κ 0 KV
− ( μY + δ Y Z )Y
dt
(P + d )

(3.7)

dV
= β Y − ( μV + δV Z )V
dt

(3.8)

dZ
= θ g (V ) + ρ [ f ( S + X ) Z max − Z ]
dt

(3.9)

dP
= ωPV ( Pmax − P)
dt

(3.10)

dK
= ωKV ( K max − K )
dt

(3.11)

where
f (N ) =

V
1 + bc
and g (V ) =
bN
a +V
1 + ( 0 )c
N

(3.12)

N can be divided into the number of non-susceptible T cells, X, and the number of susceptible T
cells, S. Therefore, N=X+S.
To understand the system, an understanding of what each term biologically represents
must first be presented. In equation (3.5), P is the fraction of new CD4+ T cells that enter the
susceptible and 1-P is the fraction of new CD4+ T cells that remain unsusceptible to the HIV
virus. The first term in equation (3.5) is α(1-P) where α is the T cell production rate. This term
represents the immigration rate of new non susceptible T cells. The second term is μX in which
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μ is the natural death rate of the unsusceptible cells. Therefore, this term represents how many
non susceptible CD4+ T cells die.
Equation (3.6) represents the dynamics of the susceptible cells in the system. The first
term, αP, describes the immigration rate of the susceptible CD4+ T cells. The second term, μS,
represents the natural death rate of the susceptible cells. The last term in equation (3.6) is

κ 0 KV

S
. This is a mass action term which describes the infection process between cells
(P + d )

and viruses. In particular,

S
describes the dynamics changes in the susceptible cells. The
(P + d )

variable, P, in this term is very important in helping determine the course of the infection and the
progression of the disease. In fact, P shows that more cells can be attacked and infected by the
virus than the immune system can combat.
Equation (3.7) has many terms and this equation determines how many productively
infected cells are in the blood. The first term is the same mass action term that is seen in
equation (3.6). The second term in equation (3.7) is ( μY + δ Y Z )Y . μY represents the death rate
of productively infected cells and δ Y Z represents how fast these dead cells are removed from the
system. Equation (3.8) describes the number of HIV particles that are produced and destroyed.
The first term in equation (3.8) is β Y . In this term, β, describes the rate at which HIV particle
cells are produced from infected cells. The second term, ( μV + δV Z )V , describes the rate at
which HIV particles are cleared and eliminated. μV is the rate in which virus particles are
cleared and δV Z represents the anti-HIV activity and elimination.
Equation (3.9) is the most complicated equation within the model because not much is
known about the dynamics of the HIV specific immune response, therefore, a general equation is
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used to model this response. The equation shows the coupling of a time dependent decline of the
CD4+ T cells and the intrinsic features of the immune response. The variable, ρ, in equation
(3.9) represents the HIV specific immune response. This response occurs independently of the
number of HIV particles that are present in the body. The function, g(V), models how the
immune response is activated depending on the quantity of the virus. The term,

ρ[ f ( S + X ) Z max ] , is the rate once primary infection occurs in which HIV will start producing
specific antibodies and the cytotoxic cells will start multiplying. Once this occurs, the immune
system will eventually become independent of the number of HIV particles and infected cells. In
equation (3.9), the function f(N) describes how the activity of the immune system is related to the
number of available uninfected cells. This function also takes account of the immune system’s
ability to combat HIV when the number of CD4+ T cells is not sufficiently high.
Equation (3.10) describes the increase in the rate of the fraction of new cells coming from
the pool of susceptible cells and how they correspond to the generation and selection of HIV
mutants. Equation (3.10) describes the rate at which the HIV infection increases due to the
reproduction of each virus particle.
The virus reproduction number is also an important value to discuss. The reproduction
number represents how quickly the virus is reproducing. The HIV reproduction number must be
above one in order to show a persistent infection. The virus reproduction number for this model
is:
R0 =

βκ 0 KS
( μY + δ Y Z )( μV + δV Z )( P + d )

(3.13)

If the values, S, Z, K could be held at fixed values, S , Z , K , P , the biological interpretation would
be that one HIV particle will generate R0 secondary particles into the host. At initial HIV
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infection with time, t, equal to 0, the virus reproduction number has a value of 10 and is
represented by the following equation:

R0 =

βκ 0 S0
( μY μV )( P0 + d )

(3.14)

This is the initial reproduction number with no anti-HIV activity. A reproduction number which
represents the presence of a fully activated anti-HIV activity with a maximum number of
susceptible cells can also be found. The reproduction number with maximum anti-HIV activity
is represented by the following equation:

R′ =

βκ 0 S0
( μY + δ Y )( μV + δV )( P0 + d )

(3.15)

In this equation, Z and K are held at fixed values, Z = Z max = 1 and K = 1 . If R′ is greater than
one, the infection will persist and cannot be cured. The calculated value of R′ is 2.75. This
value confirms that a patient with HIV will not be able to overcome the infection.
The HIV extended model is very complex and a full mathematical analysis is not
possible. However, this model is also more realistic and applicable because it takes into account
the difference between susceptible and non susceptible CD4+ T cells. Modeling with specific
parameters will help explain the system better. Most of the parameters used were found through
clinical and experimental data. (See [19]) The parameter values are described in Table 3:
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Table 3: Parameter Values used in the extended model
Parameter
α
CD4+ T cell production rate
μ
Natural death rate of uninfected cells
Initial rate at which a HIV particle
κ0
transforms a susceptible CD4+ T cell to a
productively infected cell
Death rate of productively infected cells
μY

Values
5 ×109 per day
0.02 per day
1.0 ×10−12 particles per day

δY

0.6 per day

β
μV
δV

Maximum additional elimination rate of
productively infected cell through anti-HIV
activity
HIV production rate from infected cells
Clearance rate of infectious virus particles

0.6 per day

150 particles per cell per day
6 per day

a
b
c
d
Z max

Maximum additional elimination rate of
virus particles through the anti-HIV activity
HIV dependent immune activation rate
Autonomous immune activation rate
Rate of increase of the fraction of
susceptible cells by generation and selection
of HIV mutants
Rate of increase of reproduction per virus
particle
Constant
Constant
Constant
Constant
Maximum ant-HIV activity

103
0.2
2.0
10−2
1.0

Pmax

Maximum fraction of susceptible cells

1.0

K max

Maximum infection rate of susceptible cells
per infected cell
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θ
ρ
ωP

ωK

5 per day

10−6
0.1 per day
1.4 ×10−14 particles per day
1.1× 10−15

3.4 HIV Extended model Graphs and Biological Interpretation

The numerical results of the model using the parameter values from Section 3.3 were
used to make the following graphs. Figure 1 represents the number of CD4+ T cells. Figure 2
represents the number of HIV particles. Figure 3 represents the anti-HIV activity. Each of the
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graphs represents the initial phase of the HIV infection within the first six months and supports
the model predictions.
During primary infection there are a large number of virus particles which enter the body
and start infecting the CD4+ T cells. At the start of the infection, the number of HIV particles
grows exponentially. The HIV viremia causes a temporary reduction of CD4+ T cells which
then recover and remain at a lower level than before the infection. Notice in Figure 1 and Figure
2 the increase and decrease of HIV particles and CD4+ T cells occurs at the same time around 15
days. Right after the initial infection, the anti-HIV activity mounts an attack against the invading
virus particles and we see a resurgence of CD4+ T cells. The anti-HIV activity increases rapidly
and then reaches its max. The anti-HIV activity is not the only reason the viremia starts to break
down. Note there are only a certain number of available CD4+ T cells to infect.

Figure 1: Decline of CD4+ T cells over first six months after initial infection.
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Figure 2: Increase in HIV particles within the first six months of infection.

Figure 3: Decline of anti-HIV activity within the first six months of initial infection.
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During the second phase of the infection for about ten years, the virus is slightly
suppressed and increases slowly. This is the latent period of the infection. The model shows the
immune system will hold to 50% of the normal value for about 10 years but will drop
significantly during the two years following. After about twelve years, the CD4+ T cells will
drop below 20% which is the definition of disease progression to AIDS. (See [19]). We see a
decline of anti-HIV activity. The HIV virus particles replicate freely and reach a higher
concentration than that of the primary infection. At this point, the immune system can’t control
other infections.

Figure 4: Total cell count after 12 years. Progression to AIDS occurs at y=0.2
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Figure 5: Anti-HIV activity after 12 years.

Figure 6: HIV particle increase over 12 years.

26

Surprisingly, the model predicts that the initial dose of HIV particles introduced into the
host does not play an important role in progression to disease. A highly activated CD4+ T cell
pool is one of the main determinants to infection and disease progression. If an individual is
unhealthy, their CD4+ T cell pool would be larger than normal and would favor CD4+ T cell
infection by the HIV virus. If an individual has an initial value of 1200 per mm3 CD4+ T cells,
then the progression to disease occurs much faster. If the initial value was 800 per mm3 CD4+ T
cells a much smoother progression occurs. The following graph shows the impact of initial cell
count on the infection process.

Figure 7: Total CD4+ T cell count after a 20% reduction of CD4+ T cell count (aqua), normal
reduction (blue), and initial increase by 20% of CD4+ T cell count (red).
This model also looks at the dynamics of the susceptible and non-susceptible cells. The
variable, P, in the model represents the proportion of new CD4+ T cells which are becoming
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susceptible. The higher the amount of activated CD4+ T cells, the faster the virus progresses to
disease. The initial value of P is important to the dynamics of this model. If the initial value of
P is small, the immune system will hold at 50% for about twelve years. However, if P is a larger
fraction, the progression to disease is much faster. This means through the generation and
selection of HIV mutants, the HIV virus will increase the range of CD4+ T cells tropism over
more and more CD4+ T cell clones, until after twelve years almost all of the clones are equally
susceptible to be infected by the HIV virus. (See [19]) The variable, K, is the factor which
represents the infection rate at which the CD4+ T cells increase by the generation and selection
of HIV mutants.

Figure 8: Changes in the P value and the impact on the total cell count.
The speed at which P and K change are measure by ωP and ωK . These values also play
an important role in the model and the disease progression. If the value of ωK were increased or
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decreased by a factor of five, the reduction rate of the CD4+ T cells would look similar but the
end result make be different. If ωK was decreased by a factor of five, the model predicts the
individual’s life span would increase by two years. If ωK was increased by a factor of five, the
model predicts a faster progression to disease around eight years. There is a stark difference
when the value of ωP is changed by a factor of five. If ωP is increased by the factor,
progression to disease occurs after six years.

Figure 9: Impact on CD4+ T cells when the values of ωK are varied.
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Figure 10: Impact on CD4+ T cells when the value of ωP is varied.
As seen through the graphs, P,K, ωP , and ωK are very important to the intra-host
dynamics of HIV. The effect of the rate of the fraction of susceptible cells by generation and
selection of HIV mutants is very important in determining the progression to disease. (See [19])
HIV will affect many people in many different ways. This model helps to predict the
course that HIV will take during the three stages of the disease. The model may loose
applicability for the late part of the last stage of the disease because of the many other extreme
pathological conditions. In the latter stage of the disease, the immune system is completely
compromised and is no longer able to fight infection. When this happens, a simple cold could
cause death. Understanding the course of this disease through the model presented can help
doctors and scientist find a cure for this epidemic.
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CHAPTER FOUR – HTLV-I VIRUS AND ADULT T-CELL LEUKEMIA
4.1 Introduction to the dynamics of HTLV-I

As we have seen in the previous chapter, the HIV infection takes place through cell to
cell contact with infected CD4+ T-cells and eventually takes over the immune system. A virus
that is similar and related to HIV is the first form of a human T-lymphotropic virus or HTLV.
Just as HIV can lead to the AIDS virus, HTLV-I can lead to many diseases, including adult Tcell leukemia/lymphoma. Actively infected T-cells can infect other T-cells and can eventually
convert to ATL cells. This process typically happens during the latent phase of the virus.
HTLV-I shares many similarities with HIV except in the range of diseases that it causes
and how it causes these diseases. There are two major virologic differences between HIV and
HTLV-I. One difference is that HTLV-I does not destroy the CD4+ T-cells but in fact, causes
cell proliferation and transformation. The other is that HTLV-I has a low replication rate but a
high fidelity of replication, which results in a low viral burden and high genetic stability. This
reduces the possibility of immune escape. (See [14])
HTLV-I is an enveloped double stranded RNA retrovirus which attacks the CD4+ Tcells. Transmission of HTLV-I is mainly associated with the cells. The cells receive this virus
through a glucose transporter called glut-1. Once received, the virus inserts a DNA copy into the
host cell. The virus replicates with each mitotic cell division. As cells continue to divide, the
virus spreads. HTLV-I will remain latent for many years before the virus causes Adult T-cell
leukemia to manifest. The latently infected cells contain the virus but do not produce DNA,
therefore, the cells are incapable of contagion. This chapter examines a math model which
examines the process of how HTLV-I causes ATL.
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Adult T-cell leukemia or lymphoma is a non-Hodgkins lymphoma. Adult T-cell
leukemia occurs first, which is a cancer of the cells. Lymphona also occurs and is a cancer
which attacks the B-lymphocytes and the lymphatic system. There are four distinct clinical
forms of ATL. The disease can be classified as acute ATL, chronic ATL, lymphoma, and
smoldering ATL. Once ATL develops, most individuals will survive for only a year or two. The
median survival rate for the acute and lymphoma subtypes is less than one year. Individuals with
acute or smoldering ATL may survive longer. (See [8]) Standard chemotherapy is not effective
against ATL.

4.2 Mathematical Model of HTLV-I Infection to ATL

Stilianakis and Seydel produced a basic math model that describes the T-cell dynamics of
the HTLV-I infection and the development of ATL.
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Table 4: Variables used in the Stilianakis & Sydel model
Variable
Number of susceptible CD4+ T cells
T
Number of latently infected CD4+ T cells
TL
Number of actively infected CD4+ T cells
TA
TM
Λ
κ
α
ρ
β

μT
μL
μA

Number of leukemia T-cells
Constant rate at which new CD4+ Tcells are
produced (assumed to be susceptible)
Rate at which CD4+ T cells come into
contact with actively infected cells.
Transmission rate in which latent cells
become actively infected cells
Transmission rate in which actively infected
cells convert to ATL cells
ATL proliferation rate of a classical logistic
growth model
Removal or death rate of susceptible
CD4+T-cells
Removal or death rate of latently infected
CD4+ T cells
Removal or death rate of actively infected
CD4+ T cells

This model consists of the following non-linear differential equations:
T ′ = Λ − μT T − κ TAT

(4.1)

TL′ = κ TAT − ( μ L + α )TL

(4.2)

TA′ = α TL − ( μ A + ρ )TA

(4.3)

TM′ = ρTA + β TM (1 −

33

TM
) − μ M TM
TM max

(4.4)

The terms in this model each have a biological meaning. The first term in equation (4.1)
is Λ . This term is the rate in which the new CD4+ T cells are produced. Each cell that is
produced is assumed to be susceptible to the virus. The second term in equation (4.1) represents
the rate at which all CD4+ T cells die. The last term in equation (4.1) is κ TAT and is considered
the mass action term. This term represents the infection process of susceptible cells which come
into contact with actively infected CD4+ T cells.
Equation (4.2) starts with the same mass action term that is seen in equation (4.1). The
second term is ( μ L + α )TL . Lets break this term up into two terms, μ LTL and α TL and explain
them separately. μ LTL describes how fast the latently infected cells are dying. α TL describes
how fast the latently infected cells become actively infected cells. In general, the whole term
describes the dynamics of the latently infected cells.
The first term in equation (4.3) is α TL . As seen in equation (4.2), this term represents
how fast the latently infected cells become actively infected cells. The next term is ( μ A + ρ )TA .
Again, lets break this up into two terms, μ ATA , which describes the death rate of the actively
infected cell, and ρTA , which describes how fast the actively infected cells become ATL cells.
The terms in equation (4.3) represent the dynamics of the actively infected cells and how they
change to ATL cells.
Equation (4.4) is the equation which represents the growth of the leukemia cells, which
follows the classical logistical growth function. This equation begins with ρTA . This term was
also seen in equation (4.3) and it describes the speed at which actively infected cells become
ATL cells. The second term is β TM (1 −

TM
) . This term describes the growth of the ATL cells,
TM max
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where β is the speed for which the saturation level for leukemia cells is reached and TM max is the
maximum amount of ATL cells that can be attained. The last term, μ M TM , describes the death
rate of the ATL cells. This equation illustrates the dynamics of the ATL or leukemia cells in the
body.
The virus reproduction number for this model is:

R0 =

ακ T0
( μ L + α )( μ A + ρ )

(4.5)

This number helps to determine how fast the disease will spread throughout the body. R0
represents the number of secondary infections caused by one primary infected cell introduced
into the pool of susceptible CD4+ T cells during the infection period. (See [18]) If R0 > 1 , a
chronic infection is seen. This is typical in most HTLV-I infections. If R0 ≤ 1 , the virus cannot
reproduce enough to sustain an infection. The reproduction number will be important to
determining the stability of the system.

4.3 Stability of the system

To analyze the stability of this system, we must first find the equilibrium points. In order
to find the equilibrium points, we set equations (4.1)-(4.4) equal to 0 and solve. The equation
has two possible solutions or steady states. This system can have an uninfected steady state and
a positively infected steady state. For the uninfected steady state, the T-cell population will have
the following value:
T0 =

Λ

μT
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(4.5)

The initial conditions would then be T (0) = T0 , TL (0) = 0 , TA (0) = 0 , and TM (0) = 0 . Therefore
the uninfected steady state would be E0 = (T0 , 0, 0, 0) . The positive infected steady state would
be E = (T , TL , TA , TM ) where:
T =

( μ L + α )( μ A + ρ )

ακ
Λακ − μT ( μ L + α )( μ A + ρ )
TL =
ακ ( μ L + α )
Λακ − μT ( μ L + α )( μ A + ρ )
TA =
κ ( μ L + α )( μ A + ρ )
T M2 −

( β − μ M )TM max

β

TM −

ρTATM
β

max

(4.6)

=0

We are first going to examine the stability of the uninfected steady state. For this state,
the values yield the following Jacobian matrix associated with equations (4.1)-(4.4):

⎛ − μT − κ TA
⎜
⎜ κ TA
0
J =⎜
⎜
⎜
0
⎜⎜
⎝

0

−κ T

0

−α − μ L

α

κT
−μ A − ρ

0
0

0

ρ

⎛
⎜
⎝

β ⎜1 − 2

TM
TM max

⎞
⎟
⎟
⎟
⎟
⎞
⎟
⎟ − μM ⎟
⎟
⎟
⎠
⎠

(4.7)

In the uninfected steady state, the characteristic of the polynomial is found by taking the
determinant of the Jacobian or det ( J − λ I ) . The characteristic polynomial is:
p(λ ) = ( β − μ M − λ )( μT − λ )(λ 2 + λ ( μ L + α + μ A + ρ ) + ( μ L + α )( μ A + ρ ) − ακ (4.9)
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The eigenvalues of p(λ ) = 0 are:

λ1 = β − μ M
λ2 = − μT
λ3,4 =

(4.10)

−( μ L + α + μ A + ρ )
2

( μ L + μ A + α + ρ ) 2 − 4(( μ L + α )( μ A + ρ ) − ακ
±

Λ

μT

2

The eigenvalues help determine the stability of the steady state. If λ1 = β − μ M > 0 , then the
proliferation rate of the abnormal cells are greater than the death rate and the infection increases.
If λ1 = β − μ M < 0 , then the death rate of the ATL cells is greater than the proliferation rate and
the stability will actually depend on the other eigenvalues, λ3 , λ4 . These eigenvalues are either
real or complex conjugates. In both cases, the real parts are negative if and only if the
reproduction number is less than or equal to one or:
R0 =

ακ T0
≤1
( μ L + α )( μ A + ρ )

(4.11)

If we assume that the ATL cells grow at an uncontrollable rate, then λ1 > 0 and the point,
E0 = (T0 , 0, 0, 0) , where T0 =

Λ

μT

, is an unstable saddle point. If λ1 < 0 , the reproduction number

will determine the next steady state. If R0 ≤ 1 the uninfected steady state is the only state and it
is stable. The system will move to the endemically infected steady state when R0 > 1 and this
represents a chronic infection. When this occurs, E0 will become unstable and E will exist.
For the endemically infected steady state, the Jacobian and the determinant of equations
(4.1)-(4.4) will give the following characteristic equation:

λ3 + λ2 A + λB + C = 0
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(4.12)

Where:
A = μT + μ L + μ A + ρ + α + κ TA
B = μT μ L + αμT + μT ρ + κμ LTA + κμ ATA + κρTA + ακ TA

(4.13)

C = κμ L μ ATA + καμ ATA + κρμ LTA + ακρTA
We must use the Routh-Hurwitz condition in order to further determine the stability of the
system. Note that A > 0, B > 0 and C > 0 By the Routh-Hurwitz criteria, the eigenvalues of
equation (4.12) will have negative real parts if and only if A > 0, C > 0 and AB − C > 0 . We
have already noted that A > 0 and C > 0 . We can also show AB − C > 0 , therefore, we can
determine that the eigenvalues are always negative. When the eigenvalues are negative, we can
show that steady state is stable and the infection is chronic.

4.4 Katri and Ruan Model and the stability of the system

In 2004, Katri and Ruan developed a similar model which takes into account the
difference between contact with the virus and infection by the virus. This is denoted using a κ1
in certain equations. Remember that κ represents the rate at which uninfected cells are
contacted by actively infected cells. In this model, κ1 represents the rate of infection of the Tcells by the actively infected T-cells. The equations for the Katri and Ruan model are the same
as the original model but in equation (4.2) κ is replace with κ1 and the new model is:
T ′ = Λ − μT T − κ TAT

(4.14)

TL′ = κ1TAT − ( μ L + α )TL

(4.15)

TA′ = α TL − ( μ A + ρ )TA

(4.16)

TM′ = ρTA + β TM (1 −
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TM
) − μ M TM
TM max

(4.17)

This small change in the model changes the reproduction number to be:
R0 =

ακ1T0
( μ L + α )( μ A + ρ )

(4.18)

The uninfected steady state and stability analysis remains the same as the Stilianakis &
Seydel model, however the new positive infected steady state would be E = (T , TL , TA , TM )
where:
T =

( μ L + α )( μ A + ρ )

ακ1
Λακ1 − μT ( μ L + α )( μ A + ρ )
TL =
ακ ( μ L + α )
Λακ1 − μT ( μ L + α )( μ A + ρ )
TA =
κ ( μ L + α )( μ A + ρ )
T M2 −

( β − μ M )TM max

β

TM −

ρTATM
β

max

(4.19)

=0

For this state, the values yield the following Jacobian matrix associated with equations (4.14)(4.19):
⎛ − μT − κ TA
⎜
⎜ κ1TA
0
J =⎜
⎜
⎜
0
⎜⎜
⎝

0
−α − μ L

−κ T

α

κ1T
−μ A − ρ

0

ρ

0
0
0
⎛
⎜
⎝

β ⎜1 − 2

TM
TM max

⎞
⎟
⎟
⎟
⎟
⎞
⎟
⎟ − μM ⎟
⎟
⎟
⎠
⎠

(4.20)

We will denote:
M ′ = β (1 − 2

TM
) − μM
TM max

(4.21)

Then the eigenvalues of this Jacobian are M ′ . These eigenvalues will always be negative since
TM > TM max when the infection is chronic. The Jacobian will yield the following characteristic

equation:
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λ 3 + λ 2 a1 + λ (a2 + a4 ) + (a3 + a5 ) = 0

(4.22)

Where:
a1 = κ 2TA + κμ L + κρ + κμT + ακ + κμ A
a2 = κ 2TA μ L + κ 2TAα + μT κμ L + κ 2TA μ A + κ 2TA ρ +

μ Aκμ L + μT κα + μ AκμT + κμ L ρ + καμ A + καρ + μT κρ
a3 = μT καρ + κ 2TAαρ + κ 2TA μ Aα + μT μ Aκμ L

(4.23)

+ μT κμ L ρ + μT καμ A + κ 2TA ( μ L ρ + μ L μ A )
a4 = −κ1αρ − κ1μ L ρ − κ1αμ A − κ1μ L μ A
a5 = −( μT κ1αρ + μT μ Aκ1μ L + μT κ1μ L ρ + μT κ1αμ A )

Note: The coefficients were written in this manner for convenience and comparison in some
later work by Katri & Ruan.
Again, we must use the Routh-Hurwitz condition in order to further determine the stability of the
system. According to the Routh-Hurwitz condition, the eigenvalues of equation (4.23) will have
negative real parts if and only if:
a1 > 0, (a3 + a5 ) > 0
a1 (a2 + a4 ) − (a3 + a5 ) > 0

(4.24)

Proposition 1:.The infected steady state E is asympototically stable if R0 > 1 and the
inequalities in (4.24) are satisfied. This occurs if (a) κ > κ1 , or (b) κ = κ1 .(See [6])
.In order or check that this proposition is valid, we will use the following parameters and values
estimated by Stilianakis & Seydel (See [18]).
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Table 5: Variables and Parameter Values for contagion used in the model
Parameter
Uninfected CD4+ T-cell population size
T
Latently infected CD4+ T-cell density
TL
Actively infected CD4+ T-cell density
TA
TM

Leukemic CD4+ T-cell density

μT
μL

Natural death rate of CD4+ T-cells

μA
μM
κ1

κ
β
α

ρ
TM max

λ
T0

Values
1000 / mm3
250 / mm3
1.5 / mm3
0

0.6mm3 per day
Blanket death rate of latently infected CD4+ 0.006 per day
T-cells
Blanket death rate of actively infected cells 0.05 per day
Death rate of leukemic cells

0.0005 per day

Rate uninfected CD4+ T-cells become
latently infected
Rate infected cells are contacted
Growth rate of leukemic CD4+ T-cell
population
Rate latently infected cells become actively
infected
Rate actively infected cells become
leukemic
Maximal population level of leukemic
CD4+ T-cells
Source term for uninfected CD4+ T cells
Derived quantity which represents the
CD4+ T-cell population for HTLV-I
negative persons

varies
varies
0.0003 per day
0.0004 per day
0.00004 per day

2200 / mm3
6 per day
1000 / mm3

We can use these parameter values and the estimated values of κ and κ1 , given by Stilianakis &
Seydel on the basis of parameter values from the HIV infection process, to find that R0 = 1.25 if

κ1 = 0.1 . If we take κ = κ1 = 0.1 , we find that the inequalities in equation (4.24) are satisfied and
part (b) of Proposition 1 is true. Furthermore, the steady state, E = (800,187.5,1.5,1.3) , would
be asymptotically stable. If we take κ = 0.5 and κ1 = 0.1 , we will again find that the inequalities
in equation (4.24) are satisfied and part (a) of Proposition 1 is also true. The steady state would
be E = (800,37.38, 0.3, 0.6) , which is also asymptotically stable. The following graph was
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created using the parameter values given in Table 5. The numerical simulation shows the
number of healthy CD4+ T cells decreases dramatically while the latently infected cells increase,
then remain steady.

Figure 11: Latently infected CD4+ T cells vs. Uninfected CD4+ T cells
HTLV-I is a virus in which only 5% of infected individuals will ever develop any disease
such as Adult T-cell Leukemia. We have shown through the stability analysis, we can predict
when the infection will persist and become ATL.
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CHAPTER FIVE - CONCLUSION
The interaction between HIV and the immune system is a dynamic process.
Mathematical models are used to understand this process and explore which biological
mechanisms cause disease progression. There is no cure or vaccine for HIV at the present time,
but the treatment regimes used by doctors extend the lives of HIV patients. Doctors are also
working to find a vaccine. Future work should be focused on finding the optimal treatment
schedule in order to prolong the life of patients and hopefully, find a cure.
It is unclear why some HTLV-I carriers progress to disease while the majority of them do
not do so. It is also not known why some infected individuals develop ATL and others develop
HAM/TSP. (See [8]). Further studies should focus on finding the mechanism, which causes the
virus to progress to disease and finding the genetic markers that will determine which disease the
virus will trigger. HTLV-I also has no known cure or vaccine. However, a vaccine to prevent
infection is currently being explored by scientists.
In this thesis we examined many mathematical models which are used to predict the
course of a disease. Specifically, we examined two retroviruses, HIV and HTLV-I. A basic
model and background study was given in Chapter Two. Chapter Three explored a model of the
intra-host dynamics of HIV. Graphs which were obtained from each of the models help predict
what factors are important for HIV to progress to AIDS. Chapter Four is concerned with two
different models of HTLV-I progression to ATL. Using analytical techniques we study the
stability and asymptotic stability and with the aid of SIMULINK, we obtain graphs associated
with the models to obtain information on progression of the disease.
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The mathematical models presented here are useful and can help predict the course of the
infection. However, as more clinical data about the virus becomes available, the models can be
refined further to reflect the new information.
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APPENDIX A
SIMULINK OF STILIANAKIS AND SCHENZLE EQUATIONS
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Figure 12: Simulink of Stilianakis and Schenzle equations
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APPENDIX B
MATLAB OF STILIANAKIS AND SCHENZLE EQUATIONS
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clear all
close all
clc
%first pass for plot of P=.1

in Figure 3

%days for simulation to run
days=4380;
% defining variables
alpha=5*10^9;
mu=.02;
k0=1*10^-12;
mu_Y=.6;
delta_Y=.6;
beta=150;
mu_V=6;
delta_V=5;
theta=10^-6;
rho=.1;
omega_P=1.4*10^-14;
omega_K=1.1*10^-15;
Zmax=1;
Pmax=1;
Kmax=20;
a=10^3;
b=.2;
c=2;
d=10^-2;
% initial values of intergration
N0=2.5*10^11;
X0=.7*2.5*10^11;
S0=.3*2.5*10^11;
Y0=0;
V0=1;
Z0=10^-6;
P0=.1;
K0=1;
% simulation
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sim('untitled_P_01_08')
% plotting
t=X(:,1);
x1=X(:,2);
s1=S(:,2);
y1=Y(:,2);
v1=V(:,2);
z1=Z(:,2);
p1=P(:,2);
k1=K(:,2);
figure (8)
hold on
plot (t,(x1+s1+y1)/N0,'b')
ylabel('(X+S+Y)/N0')
xlabel('Time in days')
title('Decrease of total cell count over time')
%second pass for second plot on simulation with P=.8 from figure 3
%days for simulation to run
days=4380;
% defining variables
alpha=5*10^9;
mu=.02;
k0=1*10^-12;
mu_Y=.6;
delta_Y=.6;
beta=150;
mu_V=6;
delta_V=5;
theta=10^-6;
rho=.1;
omega_P=1.4*10^-14;
omega_K=1.1*10^-15;
Zmax=1;
Pmax=1;
Kmax=20;
a=10^3;
b=.2;
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c=2;
d=10^-2;
% initial values of intergration
N0=2.5*10^11;
X0=.7*2.5*10^11;
S0=.3*2.5*10^11;
Y0=0;
V0=1;
Z0=10^-6;
P0=.8;
K0=1;
% simulation
sim('untitled_P_01_08')
% plotting
t=X(:,1);
x1=X(:,2);
s1=S(:,2);
y1=Y(:,2);
v1=V(:,2);
z1=Z(:,2);
p1=P(:,2);
k1=K(:,2);
plot (t,(x1+s1+y1)/N0,'g')
%first pass for plot of omega_k

in Figure 6

%days for simulation to run
days=4380;
% defining variables
alpha=5*10^9;
mu=.02;
k0=1*10^-12;
mu_Y=.6;
delta_Y=.6;
beta=150;
mu_V=6;
delta_V=5;
theta=10^-6;
rho=.1;
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omega_P=1.4*10^-14;
omega_K=1.1*10^-15;
Zmax=1;
Pmax=1;
Kmax=20;
a=10^3;
b=.2;
c=2;
d=10^-2;
% initial values of intergration
N0=2.5*10^11;
X0=.7*2.5*10^11;
S0=.3*2.5*10^11;
Y0=0;
V0=1;
Z0=10^-6;
P0=.3;
K0=1;
% simulation
sim('untitled_P_01_08')
% plotting
t=X(:,1);
x1=X(:,2);
s1=S(:,2);
y1=Y(:,2);
v1=V(:,2);
z1=Z(:,2);
p1=P(:,2);
k1=K(:,2);
plot (t,(x1+s1+y1)/N0,'r')
%second pass for second plot on simulation with 5*omega_k from figure 6
%days for simulation to run
days=4380;
% defining variables
alpha=5*10^9;
mu=.02;
k0=1*10^-12;
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mu_Y=.6;
delta_Y=.6;
beta=150;
mu_V=6;
delta_V=5;
theta=10^-6;
rho=.1;
omega_P=1.4*10^-14;
omega_K=5*1.1*10^-15;
Zmax=1;
Pmax=1;
Kmax=20;
a=10^3;
b=.2;
c=2;
d=10^-2;
% initial values of intergration
N0=2.5*10^11;
X0=.7*2.5*10^11;
S0=.3*2.5*10^11;
Y0=0;
V0=1;
Z0=10^-6;
P0=.3;
K0=1;
% simulation
sim('untitled_P_01_08')
% plotting
t=X(:,1);
x1=X(:,2);
s1=S(:,2);
y1=Y(:,2);
v1=V(:,2);
z1=Z(:,2);
p1=P(:,2);
k1=K(:,2);
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plot (t,(x1+s1+y1)/N0,'c')
%third pass for second plot on simulation with 1/5*omega_k from figure 6
%days for simulation to run
days=4380;
% defining variables
alpha=5*10^9;
mu=.02;
k0=1*10^-12;
mu_Y=.6;
delta_Y=.6;
beta=150;
mu_V=6;
delta_V=5;
theta=10^-6;
rho=.1;
omega_P=1.4*10^-14;
omega_K=1/5*1.1*10^-15;
Zmax=1;
Pmax=1;
Kmax=20;
a=10^3;
b=.2;
c=2;
d=10^-2;
% initial values of intergration
N0=2.5*10^11;
X0=.7*2.5*10^11;
S0=.3*2.5*10^11;
Y0=0;
V0=1;
Z0=10^-6;
P0=.3;
K0=1;
% simulation
sim('untitled_P_01_08');
% plotting
t=X(:,1);
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x1=X(:,2);
s1=S(:,2);
y1=Y(:,2);
v1=V(:,2);
z1=Z(:,2);
p1=P(:,2);
k1=K(:,2);
plot (t,(x1+s1+y1)/N0,'m')
% %first pass for plot of Omega_P in Figure 7
% %days for simulation to run
% days=4380;
%
% % defining variables
%
% alpha=5*10^9;
% mu=.02;
% k0=1*10^-12;
% mu_Y=.6;
% delta_Y=.6;
% beta=150;
% mu_V=6;
% delta_V=5;
% theta=10^-6;
% rho=.1;
% omega_P=1.4*10^-14;
% omega_K=1.1*10^-15;
% Zmax=1;
% Pmax=1;
% Kmax=20;
% a=10^3;
% b=.2;
% c=2;
% d=10^-2;
%
% % initial values of intergration
% N0=2.5*10^11;
% X0=.7*2.5*10^11;
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% S0=.3*2.5*10^11;
% Y0=0;
% V0=1;
% Z0=10^-6;
% P0=.3;
% K0=1;
% % simulation
% sim('untitled_P_01_08')
% % plotting
% t=X(:,1);
% x1=X(:,2);
% s1=S(:,2);
% y1=Y(:,2);
% v1=V(:,2);
% z1=Z(:,2);
% p1=P(:,2);
% k1=K(:,2);
% plot (t,(x1+s1+y1)/N0,'k--')
%second pass for plot of 2*Omega_P in Figure 7
%days for simulation to run
days=4380;
% defining variables
alpha=5*10^9;
mu=.02;
k0=1*10^-12;
mu_Y=.6;
delta_Y=.6;
beta=150;
mu_V=6;
delta_V=5;
theta=10^-6;
rho=.1;
omega_P=2*1.4*10^-14;
omega_K=1.1*10^-15;
Zmax=1;
Pmax=1;
Kmax=20;
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a=10^3;
b=.2;
c=2;
d=10^-2;
% initial values of intergration
N0=2.5*10^11;
X0=.7*2.5*10^11;
S0=.3*2.5*10^11;
Y0=0;
V0=1;
Z0=10^-6;
P0=.3;
K0=1;
% simulation
sim('untitled_P_01_08')
% plotting
t=X(:,1);
x1=X(:,2);
s1=S(:,2);
y1=Y(:,2);
v1=V(:,2);
z1=Z(:,2);
p1=P(:,2);
k1=K(:,2);
plot (t,(x1+s1+y1)/N0,'y')
%third pass for plot of 1/2*Omega_P in Figure 7
%days for simulation to run
days=4380;
% defining variables
alpha=5*10^9;
mu=.02;
k0=1*10^-12;
mu_Y=.6;
delta_Y=.6;
beta=150;
mu_V=6;
delta_V=5;
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theta=10^-6;
rho=.1;
omega_P=.5*1.4*10^-14;
omega_K=1.1*10^-15;
Zmax=1;
Pmax=1;
Kmax=20;
a=10^3;
b=.2;
c=2;
d=10^-2;
% initial values of intergration
N0=2.5*10^11;
X0=.7*2.5*10^11;
S0=.3*2.5*10^11;
Y0=0;
V0=1;
Z0=10^-6;
P0=.3;
K0=1;
% simulation
sim('untitled_P_01_08')
% plotting
t=X(:,1);
x1=X(:,2);
s1=S(:,2);
y1=Y(:,2);
v1=V(:,2);
z1=Z(:,2);
p1=P(:,2);
k1=K(:,2);
plot (t,(x1+s1+y1)/N0,'k')
legend('P=.1','P=.8','Omega_K_&_P','5*Omega_K','1/5*Omega_K','2*Omega_P','.5*
Omega_P')
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